Its crazy the way people on HC interpret these kinds of announcements. We will not be seeing anything of real importance for at lest 18-24months. DYOR and don't get sucked in by all the folks on here trying to 'wish' their way to a Disallowed.
Study Type :Interventional (Clinical Trial)
Estimated Enrollment :32
participantsAllocation:Non-Randomized
Intervention Model:Sequential
AssignmentMasking:None (Open Label)
Primary Purpose:Treatment
Official Title:An Open Label, Multi-Center, Dose Escalation/Expansion, Phase 1 Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
EstimatedStudy Start Date :October 30, 2020
Estimated Primary Completion Dateecember 2022
Estimated Study Completion Dateecember 2022
- Forums
- ASX - By Stock
- Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial
Its crazy the way people on HC interpret these kinds of...
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $396.8M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.2¢ | $11.62K | 217.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 2518212 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 146482 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 295345 | 0.053 |
26 | 2367697 | 0.052 |
38 | 4333284 | 0.051 |
54 | 4458280 | 0.050 |
18 | 2208068 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 679771 | 17 |
0.055 | 2506096 | 10 |
0.056 | 2745820 | 14 |
0.057 | 759484 | 9 |
0.058 | 1339682 | 11 |
Last trade - 10.24am 22/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |